Effect of curcumin in treatment of respiratory syndrome of corona

Evaluation the effectiveness of curcumin in the treatment of patients with covid-19 sever acute respiratory syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200418047119N1

Enrollment

Registered

2020-09-01

Start date

2020-08-31

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19. Covid-19 disease

Interventions

Intervention 1: Intervention group: Patients with acute respiratory syndrome of corona who are supposed to receive curcumin daily in addition to the usual medications, so that they take three of the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All people with acute respiratory syndrome of corona

Exclusion criteria

Exclusion criteria: Patients with high risk or patients with acute respiratory conditions who enter the ICU from the beginning

Design outcomes

Primary

Measure	Time frame
Body temperature. Timepoint: Body temperature is measured at the beginning of the study, on the third and seventh days. Method of measurement: Thermometer.;Oxygen saturation. Timepoint: The percentage of oxygen saturation is measured at the beginning of the study, on the third and seventh days. Method of measurement: Oxymeter.;Lung inflammation observed with CT scan. Timepoint: The CT scan image is taken at the beginning of the study and on the third and seventh days. Method of measurement: CT-scan imaging.	—

Measure

Time frame

Body temperature. Timepoint: Body temperature is measured at the beginning of the study, on the third and seventh days. Method of measurement: Thermometer.;Oxygen saturation. Timepoint: The percentage of oxygen saturation is measured at the beginning of the study, on the third and seventh days. Method of measurement: Oxymeter.;Lung inflammation observed with CT scan. Timepoint: The CT scan image is taken at the beginning of the study and on the third and seventh days. Method of measurement: CT-scan imaging.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajad Moradi

Kermanshah University of Medical Sciences

sajadmoradi28@gmail.com0988334276489

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026